Latest filing published 09 Mar 2010 for Sonnet BioTherapeutics Holdings, Inc., €191k.
Insider track record
No signal scores available.
Palisades Master Fund LP: trading record in brief
Palisades Master Fund LP discloses dealings in 2 companies, chiefly Sonnet BioTherapeutics Holdings, Inc. and Oxford Media, Inc. In total, 33 filings cover trades dated from 16 June 2006 to 5 March 2010.
On the market, this insider has only sold: 33 sales, €1.3M in total. In 2010 alone, the filings show no purchases and 1 sale.
The latest filing, published on 9 March 2010, reports an open-market sale of €191k in Sonnet BioTherapeutics Holdings, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Palisades Master Fund LP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 133,164 shares@ US$1.95Common stock, par value $.0001 per share (the"Common Stock")SEC:0001144204-10-012213:0
- 5,723 shares@ US$7.00Common stock, par value $.0001 per share ("Common Stock")SEC:0001144204-08-046700:0
- 4,621 shares@ US$6.95Common stock, par value $.0001 per share (the"Common Stock")SEC:0001144204-08-044061:0
- 1,000 shares@ US$6.97Common stock, par value $.0001 per share (the"Common Stock")SEC:0001144204-08-042137:0
- 6,010 shares@ US$0.69Common stock, par value $.0001 per share (the"Common Stock")SEC:0001144204-08-040664:0
- 300,000 shares@ US$0.57Common stock, par value $.0001 per share (the"Common Stock")SEC:0001144204-08-038437:0
- 65,000 shares@ US$0.58Common stock, par value $.0001 per share (the"Common Stock")SEC:0001144204-08-038184:0
- 28,700 shares@ US$0.6984Common stock, par value $.0001 per share (the"Common Stock")SEC:0001144204-08-033445:0
- 210,000 shares@ US$0.5715Common stock, par value $.0001 per share(the "Common Stock")SEC:0001144204-08-027276:0
- 890,000 shares@ US$0.58Common stock, par value $.0001 per share (the "Common Stock"SEC:0001144204-08-026603:0
- 60,000 shares@ US$0.5713Common stock, par value $.0001 per share (the "Common Stock"SEC:0001144204-08-025683:0
- 431,034 shares@ US$0.5713Common stock, par value $.0001 per share (the"Common Stock")SEC:0001144204-08-023781:0
- 25,587 shares@ US$0.5713Common StockSEC:0001144204-08-023781:1
- 2,500 shares@ US$0.5651Common stock, par value $.0001 per share (the"Common Stock")SEC:0001144204-08-020930:0
- 20,750 shares@ US$0.822Common stock, par value $.0001 per share (the "Common Stock"SEC:0001144204-08-015325:0
- 5,800 shares@ US$0.615Common stock, par value $.0001 per share (the "Common Stock"SEC:0001144204-08-010420:0
- 12,500 shares@ US$0.629Common stock, par value $.0001 per share (the "Common Stock"SEC:0001144204-08-010420:1
- 5,500 shares@ US$0.637Common stock, par value $.0001 per shareSEC:0001144204-08-007077:0
- 195,000 shares@ US$0.635Common stock, par value $.0001 per share (the "Common Stock"SEC:0001144204-08-006217:0
- 170,000 shares@ US$0.63Common stock, par value $.0001 per share (the "Common Stock"SEC:0001144204-08-006217:1
- 2,500 shares@ US$0.738Common stock, par value $.0001 per share (the "Common Stock"SEC:0001144204-08-006217:2
- 272,728 shares@ US$0.55Common stock, par value $.0001 per share (the "Common Stock"SEC:0001144204-08-002061:0
- 2,500 shares@ US$1.00Common stock, par value $.0001 per share (the "Common Stock"SEC:0001144204-07-052072:0
- 425,100 shares@ US$0.0125Common StockSEC:0001144204-07-049984:0
- 48,500 shares@ US$0.0305Common StockSEC:0001144204-07-039270:0
25 of 33 declarations